Have a personal or library account? Click to login
Percutaneous parametrial dose escalation in women with advanced cervical cancer: feasibility and efficacy in relation to long-term quality of life Cover

Percutaneous parametrial dose escalation in women with advanced cervical cancer: feasibility and efficacy in relation to long-term quality of life

Radiology and Oncology
Volume 52 (2018): Issue 3 (September 2018)
By: Sati Akbaba,  Jan Tobias Oelmann-Avendano,  Tilman Bostel,  Harald Rief,  Nils Henrik Nicolay,  Juergen Debus,  Katja Lindel and  Robert Foerster  
Open Access
|Sep 2018

Authors

Sati Akbaba

Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany

Jan Tobias Oelmann-Avendano

Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany

Tilman Bostel

Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany

Harald Rief

Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany
Gemeinschaftspraxis Strahlentherapie Bonn-Rhein-Sieg, Bonn, Germany

Nils Henrik Nicolay

Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany
Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Department of Radiation Oncology, University Hospital Freiburg, Freiburg, Germany

Juergen Debus

Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany
Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Katja Lindel

Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany
Department of Radiation Oncology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany

Robert Foerster

robert.foerster@usz.ch

Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany
Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
DOI: https://doi.org/10.2478/raon-2018-0029 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 320 - 328
Submitted on: Feb 14, 2018
|
Accepted on: May 9, 2018
|
Published on: Sep 11, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
cervical cancer,
parametrial boost,
quality of life,
radiotherapy
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2018 Sati Akbaba, Jan Tobias Oelmann-Avendano, Tilman Bostel, Harald Rief, Nils Henrik Nicolay, Juergen Debus, Katja Lindel, Robert Foerster, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 52 (2018): Issue 3 (September 2018)Next article